ArticlePLOS mental health2025
The effect of weight loss on brain age in schizophrenia spectrum disorders.
Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Individuals with schizophrenia spectrum disorders (SSDs) suffer from metabolic conditions including type 2 diabetes (T2D) and obesity. Moreover, they are at a high risk for cardiovascular disease and this could lead to a shortened life expectancy. Obesity is one of common comorbid conditions in SSDs, which has adverse effects on brain health. However, it is still unknown how metabolic disorders affect brain anatomy in SSDs, and the impacts of weight loss from pharmacological interventions are yet to be studied. This study includes a total of 48 patients with SSDs from three different clinical trials focusing on weight loss interventions. We acquired metabolic parameters, brain anatomical MRI, body mass index (BMI), cognition, and psychopathology scores at baseline and endpoint. We used a convolutional neural network-based classifier to calculate each patient's brain-age gap estimate (brainAGE) based on high-quality brain structural T1 images. We examined the relationship between the reduction in BMI and brainAGE between two timepoints. There was a significant reduction in BMI (p < 0.001) between two timepoints. Additionally, the analysis revealed that none of the cognitive, or psychopathology measures demonstrated significant differences between the timepoints (p > 0.05). The results of the multiple regression analysis showed a positive association between the reduction in BMI and brainAGE (F(2,44) = 3.69, p = 0.03). Furthermore, there were no noteworthy associations observed between brainAGE and the aforementioned parameters (p > 0.05). This study revealed a positive correlation between brainAGE and significant weight loss in SSDs with comorbid obesity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.